Timothy Archer, President and CEO of Lam Research (LRCX) and a director at Johnson Controls (JCI), has filed 37 Form 4 transactions across the two companies, with a pronounced sell-side bias. His open-market sales in LRCX total roughly $38.5 million, including $18.6 million on December 17, 2025, and $8.2 million on the same date, followed by $11.7 million on July 2, 2026. These sales were paired with option exercises (coded M) of about $2.0 million and $0.9 million, respectively, indicating a mechanical conversion of equity into cash rather than a fresh accumulation of shares. Notably, Archer has recorded zero open-market purchases (code P) across the entire filing history, underscoring a consistent pattern of monetizing vested awards rather than adding to his position.
The remaining activity is dominated by non-discretionary events: tax withholding (code F) and equity grants (code A) tied to compensation cycles. On February 27, 2026, Archer saw four separate F transactions in LRCX totaling roughly $40.3 million, alongside two zero-value A grants, reflecting the settlement of performance-based awards. Similar but smaller F transactions occurred in JCI on March 4, 2026 ($156,100) and March 12, 2025 ($111,411), with matching A grants. A gift (code G) of zero value on February 24, 2026, and multiple M exercises with no reported value further confirm that his filings are driven by scheduled vesting and tax obligations, not discretionary buying. The recent three-month window shows only sales and mechanical events, with no purchases, reinforcing a steady reduction in his LRCX stake while maintaining a passive holding in JCI.
AI-assisted summary